134 related articles for article (PubMed ID: 37485860)
1. Multi-combined QSAR, molecular docking, molecular dynamics simulation, and ADMET of Flavonoid derivatives as potent cholinesterase inhibitors.
Soufi H; Moussaoui M; Baammi S; Baassi M; Salah M; Daoud R; El Allali A; Belghiti ME; Moutaabbid M; Belaaouad S
J Biomol Struct Dyn; 2023 Jul; ():1-15. PubMed ID: 37485860
[TBL] [Abstract][Full Text] [Related]
2. In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies.
Moussaoui M; Baassi M; Baammi S; Soufi H; Salah M; Daoud R; El Allali A; Belghiti ME; Belaaouad S
J Biomol Struct Dyn; 2023; 41(23):13646-13662. PubMed ID: 37203327
[TBL] [Abstract][Full Text] [Related]
3. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
[TBL] [Abstract][Full Text] [Related]
4. Design of novel isoxazole derivatives as tubulin inhibitors using computer-aided techniques: QSAR modeling,
Moukhliss Y; Koubi Y; Zafar I; Alaqarbeh M; Maghat H; Sbai A; Lakhlifi T; Bouachrine M
J Biomol Struct Dyn; 2024 Feb; ():1-12. PubMed ID: 38353497
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
[TBL] [Abstract][Full Text] [Related]
6. QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate.
Edache EI; Uzairu A; Mamza PA; Shallangwa GA
J Genet Eng Biotechnol; 2022 Dec; 20():88. PubMed ID: 35730025
[TBL] [Abstract][Full Text] [Related]
7. Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors.
Khamouli S; Belaidi S; Ouassaf M; Lanez T; Belaaouad S; Chtita S
J Biomol Struct Dyn; 2022 Feb; 40(3):1285-1298. PubMed ID: 32964807
[TBL] [Abstract][Full Text] [Related]
8.
Shirvani P; Fassihi A
J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential FAK inhibitors using mol2vec molecular descriptor-based QSAR, molecular docking, ADMET study, and molecular dynamics simulation.
Hang NT; My TTK; Van Anh LT; Van Anh PT; Anh TDH; Van Phuong N
Mol Divers; 2024 Apr; ():. PubMed ID: 38582821
[TBL] [Abstract][Full Text] [Related]
11. 4-Phthalimidobenzenesulfonamide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: DFTs, 3D-QSAR, ADMET, and Molecular Dynamics Simulation.
Ejaz SA; Fayyaz A; Mahmood HMK; Aziz M; Ejaz SR; Alkhuriji AF; Al-Megrin WAI; Aborode AT; Batiha GE
Neurodegener Dis; 2022; 22(3-4):122-138. PubMed ID: 36288689
[TBL] [Abstract][Full Text] [Related]
12. QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors.
Faris A; Ibrahim IM; Alnajjar R; Hadni H; Bhat MA; Yaseen M; Chakraborty S; Alsakhen N; Shamkh IM; Mabood F; M Naglah A; Ullah I; Ziedan N; Elhallaoui M
J Biomol Struct Dyn; 2023 Dec; ():1-30. PubMed ID: 38059345
[TBL] [Abstract][Full Text] [Related]
13.
Akabli T; Toufik H; Lamchouri F
J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
[TBL] [Abstract][Full Text] [Related]
14. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
Daoud I; Melkemi N; Salah T; Ghalem S
Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
[TBL] [Abstract][Full Text] [Related]
15. Identification of promising inhibitory heterocyclic compounds against acetylcholinesterase using QSAR, ADMET, biological activity, and molecular docking.
Nguyen HD; Kim MS
Comput Biol Chem; 2023 Jun; 104():107872. PubMed ID: 37119698
[TBL] [Abstract][Full Text] [Related]
16. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
Hasan AH; Murugesan S; Amran SI; Chander S; Alanazi MM; Hadda TB; Shakya S; Pratama MRF; Das B; Biswas S; Jamalis J
Bioorg Chem; 2022 Feb; 119():105572. PubMed ID: 34971946
[TBL] [Abstract][Full Text] [Related]
17. Design of novel benzimidazole derivatives as potential α-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation studies.
Abchir O; Daoui O; Belaidi S; Ouassaf M; Qais FA; ElKhattabi S; Belaaouad S; Chtita S
J Mol Model; 2022 Mar; 28(4):106. PubMed ID: 35352175
[TBL] [Abstract][Full Text] [Related]
18. Multi-target approach for Alzheimer's disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-
Adeowo FY; Ejalonibu MA; Elrashedy AA; Lawal MM; Kumalo HM
J Biomol Struct Dyn; 2021 Jul; 39(11):3825-3841. PubMed ID: 33030113
[TBL] [Abstract][Full Text] [Related]
19. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
[TBL] [Abstract][Full Text] [Related]
20. 2,4,6-Trimethoxy chalcone derivatives: an integrated study for redesigning novel chemical entities as anticancer agents through QSAR, molecular docking, ADMET prediction, and computational simulation.
Chitre TS; Mandot AM; Bhagwat RD; Londhe ND; Suryawanshi AR; Hirode PV; Bhatambrekar AL; Choudhari SY
J Biomol Struct Dyn; 2024 Feb; ():1-24. PubMed ID: 38321946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
